Patients with rare skin cancer face 40% recurrence rate
Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40%—markedly higher than the recurrence rates for melanoma and other skin cancers, according to research published today in JAMA Dermatology.
Feb 23, 2022
0
1